Good morning :)
Switch to
Place Order

Strides Pharma Science Ltd

STAR
Health CarePharmaceuticals
SmallcapWith a market cap of ₹3,136 cr, stock is ranked 620
Moderate RiskStock is 2.53x as volatile as Nifty
349.251.70% (+5.85)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹3,136 cr, stock is ranked 620
Moderate RiskStock is 2.53x as volatile as Nifty

Key Metrics

PE RatioPE RatioPB RatioPB RatioDividend YieldDiv. Yield
-6.821.11
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
38.164.820.92%

Forecast & RatingsDetailed Forecast 

100%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Strides Pharma Science is a vertically integrated global pharmaceutical company engaged in the development and manufacturing of active pharmaceutical ingredients and formulations, as well as biotech

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Financial TrendFinancial statements 

2019202020212022+2.55+2.91+3.52+3.20+0.32+0.04+0.27-0.46
Revenue
Profit
Loss
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

High Pledged Promoter Holding
Lower pledged promoter holdings is considered better

A significant proportion of promoter holdings is pledged

Decreased Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has decreased by 2.57%

See detailed holdings

Recent EventsAll events 

Press Release 
Announced OnAug 8, 2022

Strides Pharma Science Limited has informed the Exchange about press release dated 08-Aug-2022 titled Strides announces successful completion of US FDA inspection at its Singapore facility | Download

Strides Pharma Science Limited has informed the Exchange about press release dated 08-Aug-2022 titled Strides announces successful completion of US FDA inspection at its Singapore facility | Download

Transcript of Analysts/Institutional Investor Meet/Con. Call 
Announced OnAug 4, 2022

Strides Pharma Science Limited has informed the Exchange about Transcript of Analysts/Institutional Investor Meet/Con. Call | Download

Strides Pharma Science Limited has informed the Exchange about Transcript of Analysts/Institutional Investor Meet/Con. Call | Download

Cash Dividend 
Ex. DateAug 5, 2021

Final • Div/Share: ₹ 2.5

See all events